C22H27ClFN7O4S
540 g/mol
APIDanger
Encorafenib
CAS1269440-17-6
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Encorafenib is a small molecule compound that functions as a BRAF inhibitor, targeting key enzymes in the MAPK signaling pathway. It is supplied as a pharmaceutical raw material for use in research and manufacturing of cancer therapies.
Pharmaceutical manufacturingResearch compound for MAPK pathway studiesAPI for melanoma drug formulations
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1269440-17-6
Related Compounds
SimilarStructure SimilarSimilarity 0.77
Methyl (S)-(1-((4-(3-(3-amino-5-chloro-2-fluorophenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
CAS1269440-78-9
pharmaceutical intermediate
ReferenceSame Category
Pyrotinib
CAS1269662-73-8
pharmaceutical raw material
ReferenceSame Category
Hydroxycarbamide
CAS127-07-1
pharmaceutical raw material
ReferenceSame Category
Sulfacetamide sodium
CAS127-56-0
pharmaceutical raw material
ReferenceSame Category
Sulfamerazine sodium
CAS127-58-2
pharmaceutical raw material
Safety Reference
Danger
H351Suspected of causing cancer
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
H373May cause damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H411Toxic to aquatic life with long lasting effects
Identifiers
IUPAC Name
methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate
InChIKey
CMJCXYNUCSMDBY-ZDUSSCGKSA-N
SMILES
C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=C(C(=CC(=C3)Cl)NS(=O)(=O)C)F)C(C)C)NC(=O)OC
Synonyms (21)
- Encorafenib (JAN/USAN/INN)
- Braftovi
- Braftovi (TN)
- Encorafenib
- Encorafenib (LGX818)
- Encorafenib (Standard)
- Encorafenib Refrence standard
- LGX-818(Encorafenib)
- LY2606368 mesylate
- US9314464, 9
- encorafenibum